CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading artificial intelligence (AI)-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has included its ...

Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. About 6.2 million Americans battle ...

August 12, 2011 — Older patients are more likely than younger patients with a similar low left ventricular ejection fraction to have cognitive decline, report researchers. "Cognitive dysfunction due ...

Using an AI-powered electrocardiogram to diagnose low ejection fraction produced a cost-effectiveness ratio of $27,858 per quality-adjusted life year, according to a study published Oct. 25 in Mayo ...

Please provide your email address to receive an email when new articles are posted on . An AI model may help to detect asymptomatic heart failure using a single-lead ECG. Early diagnosis could improve ...

San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...

Credit: Eko Health. The FDA clearance was based on data from a prospective clinical study of 3456 patients. The Food and Drug Administration (FDA) has cleared the Eko Low Ejection Fraction Tool (ELEFT ...